To Test the Effect of Selected Fibres and Flours in Flat Bread on Post-Prandial Blood Glucose and Insulin Responses in Healthy Indian Population
To Evaluate the Effect of 4 Different Flour Compositions of Selected Fibres and Flours, on Post-prandial Plasma Glucose (PPG) and Serum Insulin Levels in Normal Indian Healthy Subjects
1 other identifier
interventional
50
1 country
1
Brief Summary
Double-blind, randomized, controlled, cross-over design with 3 test products and one control product. To evaluate the effect of 4 different flour compositions (guar gum 2% and 4%, chickpea flour 15% and barley flour 2% and 5%) of selected fibres and flours, on post-prandial plasma (PPG) and serum insulin levels in healthy Indian subjects, after the consumption of flat bread made from 100 gram of flour compositions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Jul 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 23, 2016
CompletedFirst Posted
Study publicly available on registry
June 27, 2016
CompletedJuly 19, 2016
July 1, 2016
Same day
June 23, 2016
July 18, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive incremental area under blood glucose curve
0-120 minutes
Secondary Outcomes (1)
Total area under the serum insulin curve
0-120 minutes
Other Outcomes (7)
Cmax glucose
0-120 minutes
Tmax glucose
0-120 minutes
Slope to Cmax
0-120 minutes
- +4 more other outcomes
Study Arms (4)
Control (market standard)
PLACEBO COMPARATOR100 g wheat flour (atta)
High fibre 1
ACTIVE COMPARATOR81% wheat flour (atta) + 15% chickpea + 4% guar gum
High fibre 2
ACTIVE COMPARATOR80% wheat flour (atta) + 15% chickpea + 2% guar gum + 3% barley
High fibre 3
ACTIVE COMPARATOR77% wheat flour (atta) + 15% chickpea + 3% guar gum + 5% barley
Interventions
Eligibility Criteria
You may qualify if:
- Healthy male and female subjects between \> 20 and \< 50 years of age
- BMI of \>18 and \< 23 kg/m2
- Fasting blood glucose value of volunteer is \> 3.4 and \<6.1 mmol/litre (i.e. 62- 110 mg/dl) at screening
You may not qualify if:
- Chronic smokers, tobacco chewers and drinkers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unilever R&Dlead
Study Sites (1)
Lambda Therapeutics Research Ltd (LTRL)
Ahmedabad, Near Gujrat High Court, SG Highway, Gota, 380 061 Gujrat, India
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rakesh Patel, Dr.
Lambda Therapeutic Research Ltd.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2016
First Posted
June 27, 2016
Study Start
July 1, 2011
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
July 19, 2016
Record last verified: 2016-07